Intuitive Surgical, Inc. $ISRG Position Trimmed by Generali Investments Management Co LLC

Key Points

• Generali Investments Management reduced its Intuitive Surgical stake by 25.6% in the third quarter, selling 2,573 shares and retaining 7,493 shares worth approximately $3.05 million. Institutional investors collectively own 83.64% of the company.
• Intuitive Surgical insiders sold 12,370 shares worth roughly $4.9 million over the past 90 days, including transactions by a director and vice president conducted under pre-arranged Rule 10b5-1 plans.
• The stock maintains a “Moderate Buy” consensus, with an average analyst price target of $498.83. The company recently exceeded earnings and revenue estimates, but investors remain focused on slowing U.S. procedure growth, China-related headwinds and its premium valuation.

Generali Investments Management Co LLC lessened its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 25.6% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 7,493 shares of the medical equipment provider's stock after selling 2,573 shares during the quarter. Generali Investments Management Co LLC's holdings in Intuitive Surgical were worth $3,047,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in the company. 3Chopt Investment Partners LLC boosted its holdings in Intuitive Surgical by 5.2% in the first quarter. 3Chopt Investment Partners LLC now owns 462 shares of the medical equipment provider's stock valued at $213,000 after purchasing an additional 23 shares during the last quarter. Vermillion Wealth Management Inc. increased its holdings in Intuitive Surgical by 58.1% during the 1st quarter. Vermillion Wealth Management Inc. now owns 68 shares of the medical equipment provider's stock worth $31,000 after purchasing an additional 25 shares during the last quarter. W.G. Shaheen & Associates DBA Whitney & Co increased its holdings in Intuitive Surgical by 1.0% during the 1st quarter. W.G. Shaheen & Associates DBA Whitney & Co now owns 2,542 shares of the medical equipment provider's stock worth $1,172,000 after purchasing an additional 25 shares during the last quarter. Blue Fin Capital Inc. raised its position in shares of Intuitive Surgical by 0.5% in the 1st quarter. Blue Fin Capital Inc. now owns 4,794 shares of the medical equipment provider's stock valued at $2,210,000 after purchasing an additional 25 shares in the last quarter. Finally, Red Spruce Capital LLC raised its position in shares of Intuitive Surgical by 4.1% in the 2nd quarter. Red Spruce Capital LLC now owns 640 shares of the medical equipment provider's stock valued at $255,000 after purchasing an additional 25 shares in the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, Director Gary Guthart sold 10,000 shares of the stock in a transaction on Tuesday, August 11th. The stock was sold at an average price of $400.00, for a total transaction of $4,000,000.00. Following the completion of the transaction, the director directly owned 1,245,679 shares of the company's stock, valued at approximately $498,271,600. This trade represents a 0.80% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, VP Fredrik Widman sold 1,089 shares of the firm's stock in a transaction dated Tuesday, September 15th. The shares were sold at an average price of $374.44, for a total value of $407,765.16. Following the transaction, the vice president directly owned 1,026 shares of the company's stock, valued at $384,175.44. This represents a 51.49% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 12,370 shares of company stock valued at $4,891,989. 0.60% of the stock is currently owned by company insiders.

More Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Analysts at Erste Group Bank raised their earnings estimates for ISRG, suggesting improved expectations for the company’s upcoming results and longer-term profitability. Erste Group Bank Analysts Boost Earnings Estimates for ISRG
• Positive Sentiment: Recent results have shown double-digit growth in robotic-surgery procedures, revenue and Intuitive Surgical’s installed base of systems. That underlying operating momentum remains a key support for the investment case despite the stock’s broader underperformance this year. Intuitive Surgical Valuation and Growth
• Positive Sentiment: The shares increased in the prior session and outperformed the broader market that day, reflecting some investor support ahead of the earnings release. ISRG Beats Stock Market Upswing
• Neutral Sentiment: Investors are focused on third-quarter procedure growth, da Vinci system demand, revenue, margins and other operating metrics—not just earnings per share and revenue—to determine whether recent momentum is sustainable. ISRG Ahead of Q3 Earnings
• Negative Sentiment: Expectations are tempered by slowing U.S. procedure growth and headwinds in China. These issues could pressure system placements and margins, increasing the risk of an earnings-related market reaction. ISRG Q3 Earnings Preview
• Negative Sentiment: Despite double-digit growth, shares have declined substantially during 2026 and trade at a premium valuation. Investors are questioning whether a valuation around 33 times expected earnings adequately reflects the company’s growth prospects, particularly if procedure growth slows. ISRG Valuation Analysis

Analyst Ratings Changes

A number of brokerages recently issued reports on ISRG. JPMorgan Chase & Co. dropped their price target on shares of Intuitive Surgical from $550.00 to $450.00 and set an "overweight" rating for the company in a research note on Friday, July 17th. Evercore set a $430.00 price objective on shares of Intuitive Surgical in a research note on Monday, July 6th. Sanford C. Bernstein reissued an "outperform" rating on shares of Intuitive Surgical in a report on Wednesday, August 12th. Piper Sandler reissued an "overweight" rating on shares of Intuitive Surgical in a research report on Friday, August 21st. Finally, BMO Capital Markets restated an "outperform" rating on shares of Intuitive Surgical in a research note on Monday, July 20th. One investment analyst has rated the stock with a Strong Buy rating, twenty-two have issued a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $498.83.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG opened at $426.70 on Monday. The stock has a 50 day simple moving average of $391.43 and a 200-day simple moving average of $409.44. The company has a market cap of $150.74 billion, a PE ratio of 48.88, a P/E/G ratio of 3.22 and a beta of 1.46. Intuitive Surgical, Inc. has a 12-month low of $328.57 and a 12-month high of $603.88.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its quarterly earnings data on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share for the quarter, topping the consensus estimate of $2.48 by $0.32. The business had revenue of $2.89 billion during the quarter, compared to the consensus estimate of $2.83 billion. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The company's quarterly revenue was up 18.4% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.81 earnings per share. Sell-side analysts forecast that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company's primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.